Search Results
                            266 Results for 'Therapeutics & Vaccines'                        
                        
                            PAGE 9 OF 11                        
                    Technology
Compounds And Methods For Modulating Frataxin Expression
            Friedreich’s ataxia (also referred to as FA or FRDA) is a rare but fatal autosomal recessive neurodegenerative disease. With an estimated incidence of 1 in every 40,000 people, it causes progressive...            
Learn More
        Learn More
            Aseem Ansari, Graham Erwin, Matthew Grieshop | P160232US05
        
    Technology
Improved Influenza B Virus Replication for Vaccine Development
            The epidemiology of influenza Type B viruses differs from Type A; influenza B viruses primarily circulate in humans and do not cause pandemics. However, in some seasons the impact of influenza B infec...            
Learn More
        Learn More
            Yoshihiro Kawaoka, Gabriele Neumann, Jihui Ping | P160181US02
        
    Technology
SIgA Protein as Heath Supplement for Animals, Humans
            Secretory immunoglobulin A (sIgA) plays a critical role in immunity. The protein is found in breast milk and secreted in the gastrointestinal system during development and adulthood. Research suggests...            
Learn More
        Learn More
            Mark Cook, Jordan Sand | P120329US01
        
    Technology
More Stable Collagen Mimetic Peptides for Wound Healing
            Collagen is the most abundant protein in vertebrates, providing support to virtually every tissue including skin, bone and blood vessel. It is of critical importance in wound healing.Given its signifi...            
Learn More
        Learn More
            Ronald Raines, Ismet Tanrikulu | P140407US02
        
    Technology
Natural Antibiotic to Treat Clostridium Infection and More
            Bacterial resistance to antibiotics is an escalating problem, especially in hospital settings. The Centers for Disease Control recently identified Clostridium difficile as posing an “urgent” healt...            
Learn More
        Learn More
            Timothy Bugni, Thomas Wyche, Douglas Braun, Jeff Piotrowski, Nasia Safdar | P140428US02
        
    Technology
Mutations That Improve Genetic Stability of Influenza Virus for Vaccination, Gene Therapy & More
            The influenza virus is a highly contagious respiratory pathogen that causes annual epidemics and occasional pandemics. Although many studies have looked at how a host responds to infection with the vi...            
Learn More
        Learn More
            Yoshihiro Kawaoka, Satoshi Fukuyama, Shinji Watanabe | P140264US02
        
    Technology
Novel Analogs of Podophyllotoxin May Treat Cancer and Viral Infections
            Podophyllotoxin is a natural product derived from a plant. Although two clinically useful glycosylated analogs have been developed for treating cancer, podophyllotoxin is difficult to synthesize, hind...            
Learn More
        Learn More
            Jon Thorson, James Watson, Jr. | P08343US
        
    Technology
Inhibiting Metadherin/SND1 Interaction to Treat Cancer
            Metadherin (MTDH; also called AEG1 or LYRIC) is a pro-metastasis gene implicated in many types of cancer. The gene is overexpressed in more than 40 percent of primary tumors and is linked to breast ca...            
Learn More
        Learn More
            Yongna Xing, Liling Wan, Yibin Kang, Feng Guo | P140424US02
        
    Technology
Analogs of Diptoindonesin G for Breast Cancer Drug Development
            The natural product diptoindonesin G (Dip G) was first isolated in 2009 from the tree bark of Hopea mengarawan. It has shown antiproliferation effects in murine leukemia as well as immunosuppressant a...            
Learn More
        Learn More
            Wei Xu, Weiping Tang, Jitian Liu, Jill Kolesar | P170010US02
        
    Technology
Better Living Through Peptides; Improved Approach to HIV Therapy
            Human immunodeficiency virus (HIV) affects over 1.2 million Americans each year, with approximately 50,000 new infections per year. Current treatment includes HIV combination regimens comprising rever...            
Learn More
        Learn More
            Samuel Gellman, William Horne, Lisa Johnson | P08414US03
        
    Technology
Retinoic Acid: A New Treatment for Sleep Apnea and Hypopnea
            Sleep apnea affects an estimated 18 million American adults annually. People with sleep apnea can develop conditions such as systemic and pulmonary hypertension, metabolic syndrome, insomnia, neuro-in...            
Learn More
        Learn More
            Tracy Baker, Gordon Mitchell, Daryl Fields | P150330US02
        
    Technology
Nylon-3 Polymers Active Against Clostridium Difficile
            Clostridium difficile is a Gram-positive, endospore-forming anaerobe that causes life-threatening intestinal infections. These infections result in more than 14,000 deaths and billions of dollars in h...            
Learn More
        Learn More
            Samuel Gellman, Runhui Liu, Bernard Weisblum, Shonna McBride | P150214US02
        
    Technology
New and More Potent UGM Inhibitors for Treating Tuberculosis, Other Microbial Infections
            Mycobacterium tuberculosis, the causative agent of tuberculosis, is responsible for eight million human infections and two million deaths worldwide each year. M. tuberculosis infections can be treated...            
Learn More
        Learn More
            Laura Kiessling, Valerie Winton, Alexander Justen | P160093US02
        
    Technology
Peptides to Treat Alzheimer’s Disease
            Amyloid-beta (Aβ) peptides play a crucial role in Alzheimer’s disease – they are a main component of the toxic amyloid plaques found in patients’ brains. Aβ is so dangerous because it can aggr...            
Learn More
        Learn More
            Regina Murphy, Jeffrey Johnson, Patricia Cho, Xiaomeng Lu | P140391US02
        
    Technology
Skin Whitening Agent(s)
            The global cosmetics industry is a $460 billion dollar market with the skin whitening sector valued at $381 million in 2014. This growing market is projected to increase at a CAGR of 11.7%, reaching $...            
Learn More
        Learn More
            Cheng-chen Huang, Aaron Monte | T140007WO01
        
    Technology
Warfarin Promoter
            Warfarin is a “first-generation” anticoagulant that has been widely used as a multiple feeding rodenticide for more than 60 years. The prolonged use of warfarin as a rodenticide has, according to ...            
Learn More
        Learn More
            David Lewis, Michael Caldwell | T100001US02
        
    Technology
Long-Lasting, Non-Narcotic Protein for Treatment of Acute or Chronic Pain
            Millions of people in the U.S. suffer from chronic pain each year. Narcotic-based medications commonly are given for pain relief, but they are not always effective and can lead to addiction.Botulinum ...            
Learn More
        Learn More
            Eric Johnson, Sabine Pellett, William Tepp, Tony Yaksh, Marc Marino, Qinghao Xu | P130093US02
        
    Technology
Increasing Red Blood Cell Production
            Maintaining an adequate supply of oxygen to tissue is necessary for survival. The oxygen-carrying capacity of blood is governed by the concentration of red blood cells (erythrocytes). It is critical t...            
Learn More
        Learn More
            Emery Bresnick, Yoon A Kang, Skye McIver | P130326US02
        
    Technology
Treating Iron Overload with Block Copolymers
            Iron overload or hemochromatosis is a disease marked by an accumulation of iron in the blood. It typically occurs in subjects (e.g., anemia patients) receiving chronic infusions of red blood cells. Th...            
Learn More
        Learn More
            May Xiong, Zhi Liu, Yan Wang | P140395US02
        
    Technology
Generic Drug to Treat and Prevent Macular Degenerative Diseases
            More than 30 million people suffer from age-related macular degeneration (AMD), the most common cause of permanent vision loss among older adults. Few treatment options are available for AMD, or for j...            
Learn More
        Learn More
            Aparna Lakkaraju, Kimberly Toops, Li Xuan Tan | P140282US02
        
    Technology
Hormone Analogs for Treating Hypoparathyroidism
            The proper functioning of cells depends on information traveling from the extracellular environment to the cytoplasm. Most signals must be conveyed via proteins that span the cellular membrane. Many o...            
Learn More
        Learn More
            Samuel Gellman, Ross Cheloha, Thomas Gardella | P130312US03
        
    Technology
Non-Natural Peptides for Treating Diabetes
            Diabetes mellitus continues to be a chronic public health issue despite the availability of injectable insulin since the 1920s. Finding alternative treatments is the subject of intense research. In re...            
Learn More
        Learn More
            Samuel Gellman, Lisa Johnson, Alan Attie, Alan Saghatelian, Mark Keller | P130310US02
        
    Technology
Influenza Variant Grows Well in CHO Cells
            Vaccines against influenza and other viruses can be grown in Chinese Hamster Ovary (CHO) cells. Problematically, an influenza virus that is made by combining H1N1 and PR8 strains, and that is recommen...            
Learn More
        Learn More
            Yoshihiro Kawaoka, Makoto Ozawa | P100246US02
        
    Technology
Treating Fungal Infections with New Forazoline Compounds
            Fungal infections range in severity from common athlete’s foot to life-threatening illness. Treatment can be very expensive. The cost of treating systemic Candida yeast infections exceeds $31,000 pe...            
Learn More
        Learn More
            Timothy Bugni, Thomas Wyche, David Andes, Douglas Braun | P130274US02
        
    Technology
Treating Staph Infections, Toxic Shock Syndrome by Disrupting Bacteria Quorum Sensing
            ‘Staph’ infections, particularly by Staphylococcus aureus strains, can cause skin ailments and more serious conditions like heart valve inflammation and toxic shock syndrome. These strains also ar...            
Learn More
        Learn More
            Helen Blackwell, Danielle Wittenwyler, Yiftah Tal Gan | P130070US02